v3.26.1
Condensed Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 2,109,529 $ 3,567,487
Investments 5,377,685 5,943,218
Accounts receivable, net 6,384 5,812
Inventory 1,841,286 1,400,305
Prepaid expenses and other current assets 693,195 681,265
Total Current Assets 10,028,079 11,598,087
Property and equipment, net 128,325 113,929
Right-of-use assets, net 311,133 324,058
Product development costs, net of amortization of $942,887 and $833,452, respectively 1,446,414 1,257,447
Software development costs, net of amortization of $1,468,495 and $1,183,765, respectively 2,223,878 2,454,909
Goodwill 3,143,662 3,143,662
Other intangible assets, net of amortization of $7,380,550 and $7,190,101, respectively 1,224,017 1,414,466
Total Assets 18,505,508 20,306,558
Current Liabilities    
Accounts payable 344,637 563,990
Accrued expenses 1,016,063 1,128,424
Deferred revenue 231,092 239,916
Total Current Liabilities 1,591,792 1,932,330
Other long-term liabilities 269,049 282,899
Total Liabilities 1,860,841 2,215,229
Commitments and Contingencies (Note 9)
Series C Redeemable Preferred Stock    
Series C redeemable preferred stock, par value $0.0001 per share: 2,000 shares designated; 1 share issued and outstanding as of March 31, 2026 and December 31, 2025, aggregate liquidation preference of $2,000,000 as of March 31, 2026 and December 31, 2025 1,807,300 1,807,300
Stockholders’ Equity    
Preferred stock, value
Common stock, par value $0.0001 per share: 800,000,000 shares authorized; 906,059 issued and outstanding as of March 31, 2026 and December 31, 2025 91 91
Additional paid-in capital 132,601,746 132,597,001
Accumulated deficit (118,083,470) (116,632,063)
Total Stockholders’ Equity 14,837,367 16,284,029
Total Liabilities, Series C Redeemable Preferred Stock and Stockholders’ Equity 18,505,508 20,306,558
Series F Preferred Stock    
Stockholders’ Equity    
Preferred stock, value $ 319,000 $ 319,000